CXCL12 and acute myeloid leukemia: In contrast to wild-type or monomeric variants, data from transwell migration assays in two separate AML cell lines indicate that CXCL12-LD was unable to stimulate migration at 3, 30, or 300 nM concentrations (Fig. 1E, 1F).